tiprankstipranks
Trending News
More News >
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
US Market

Janux Therapeutics Inc (JANX) Ownership - Who Owns Janux Therapeutics Inc?

Compare
385 Followers

Janux Therapeutics Inc (JANX) Ownership Overview

55.01%16.40%<0.01%7.83%20.76%
55.01% Insiders
<0.01% Other Institutional Investors
7.83% ETFs
20.76% Public Companies and Individual Investors
The ownership structure of Janux Therapeutics Inc (JANX) stock is a mix of institutional, retail, and individual investors. Approximately 24.24% of the company’s stock is owned by Institutional Investors, 55.01% is owned by Insiders, and 20.76% is owned by Public Companies and Individual Investors.
The ownership structure of Janux Therapeutics Inc (JANX) stock is a mix of institutional, retail, and individual investors. Approximately 16.40% of the company’s stock is owned by Institutional Investors, 55.01% is owned by Insiders, and 7.83% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 07, 2025
xxxxxxxxxxxxx
$25342965
Oct 24, 2024
xxxxxxxxxxxxx
$178084
Oct 22, 2024
xxxxxxxxxxxxx
$53700000
Oct 18, 2024
xxxxxxxxxxxxx
$77472371

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$17064
Mar 31, 2025
xxxxxxxxxxxxx
$1352862
Mar 31, 2025
xxxxxxxxxxxxx
$26201124
Mar 31, 2025
xxxxxxxxxxxxx
$39341565

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
11,195,943Insider18.92%278,778,981
11,189,693Institution18.91%278,623,356
7,377,765Insider12.47%183,706,349
6,560,816Insider11.09%163,364,318
2,644,622Insider4.80%65,851,088
2,417,459Institution4.09%60,194,729
2,165,908Institution3.66%53,931,109
1,847,879Institution3.12%46,012,187
1,684,907Institution2.85%41,954,184
1,457,095Institution2.46%36,281,666

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,417,459Institution4.09%60,194,729
1,847,879Institution3.12%46,012,187
1,319,830Institution2.23%32,863,767
1,215,075Institution2.05%30,255,368
1,061,989Institution1.79%26,443,526
828,189Institution1.40%20,621,906
466,023Institution0.79%11,603,973
403,065Institution0.68%10,036,319
335,665Institution0.57%8,358,059
301,105Institution0.51%7,497,515

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,342,663Institution2.27%44,576,412
795,993Institution1.35%19,820,226
616,287Institution1.04%15,752,296
505,992Institution0.86%16,798,934
291,791Institution0.49%7,265,596
269,484Institution0.46%6,710,152
157,485Institution0.27%5,228,502
154,078Institution0.26%3,938,234
128,513Institution0.22%4,266,632
79,621Institution0.13%2,035,113

FAQ

Who Owns Janux Therapeutics Inc (JANX)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 55.01% is held by insiders, and 20.76% is held by retail investors.
    What percentage of Janux Therapeutics Inc (JANX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately <0.01% of Janux Therapeutics Inc (JANX) stock is held by institutional investors.
      What percentage of Janux Therapeutics Inc (JANX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 20.76% of Janux Therapeutics Inc (JANX) stock is held by retail investors.
        Who owns the most shares of Janux Therapeutics Inc (JANX)?
        Ra Capital Management, Llc owns the most shares of Janux Therapeutics Inc (JANX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis